CBLL
CeriBell, Inc.NasdaqResearch view
Healthcare · Electromedical & Electrotherapeutic Apparatus · Small-cap · SEC EDGAR FY 2025-12-31
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-12-31SectorHealthcare
Market Cap$940.3M
Enterprise Value$899.8M
Income$-53.4M
Sales$89.1M
Book/sh$4.05
Cash/sh$1.05
Dividend TTM—
Payout—
Employees—
IPO—
Quick Ratio9.35
Current Ratio9.73
Debt/Eq—
EPS (ttm)$-1.46
EPS this Y56.9%
EPS past 3/5Y—
Sales past 3/5Y—
EPS Y/Y TTM56.9%
Sales Y/Y TTM36.1%
Shs Outstand38.38M
ROA-27.3%
ROE-34.4%
ROIC-50.8%
Gross Margin87.9%
Oper. Margin-65.6%
Profit Margin-60.0%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$45.2M
2023
$65.4M
2024
$89.1M
2025
Financials — annual
SEC EDGAR · last 3 FY · tap a row to explain it| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $45.2M | $65.4M | $89.1M |
| Gross Profit | $38.2M | $56.8M | $78.3M |
| Operating Income | $-30.0M | $-39.7M | $-58.4M |
| Net Income | $-29.5M | $-40.5M | $-53.4M |
| Diluted EPS | $-5.56 | $-3.39 | $-1.46 |
| Operating Cash Flow | $-29.2M | $-35.0M | $-40.8M |
| Free Cash Flow | $-30.1M | $-36.4M | $-41.6M |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
FY25 cash-flow waterfall
Cash-flow detail unavailable in this filing.
—
COMMUNITY · $CBLL0 theses
POST YOUR TAKE →Related Stocks
Click to exploreSame Industry · Electromedical & Electrotherapeutic Apparatus
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.